tiprankstipranks
Advertisement
Advertisement

BMY Stock Latest News

Bristol Myers Squibb (BMY) Adopts Nvidia’s AI Computing System for Drug Discoveries
Market NewsBristol Myers Squibb (BMY) Adopts Nvidia’s AI Computing System for Drug Discoveries
14h ago
BMY
NVDA
Bristol Myers to expand compute infrastructure to deploy Nvidia DGX SuperPOD
PremiumThe Fly
Bristol Myers to expand compute infrastructure to deploy Nvidia DGX SuperPOD
18h ago
BMY
NVDA
Bristol Myers expands compute infrastructure to deploy NVIDIA DGX SuperPOD
PremiumThe Fly
Bristol Myers expands compute infrastructure to deploy NVIDIA DGX SuperPOD
18h ago
BMY
NVDA
Bristol Myers Squibb call volume above normal and directionally bullish
PremiumThe Fly
Bristol Myers Squibb call volume above normal and directionally bullish
5d ago
BMY
Best ETFs to Invest In, According to AI Analyst, 7/15/2026
PremiumMarket News
Best ETFs to Invest In, According to AI Analyst, 7/15/2026
5d ago
VZ
BMY
BMY’s IZABRIGHT-Lung02 Trial Targets Growth in EGFR Lung Cancer
PremiumCompany AnnouncementsBMY’s IZABRIGHT-Lung02 Trial Targets Growth in EGFR Lung Cancer
6d ago
BMY
Agilent receives FDA approval for PD-L1 IHC 28-8 pharmDx assay
Premium
The Fly
Agilent receives FDA approval for PD-L1 IHC 28-8 pharmDx assay
7d ago
A
BMY
Bristol Myers says FDA accepts NDA for mezigdomide
Premium
The Fly
Bristol Myers says FDA accepts NDA for mezigdomide
8d ago
BMY
BMY Advances Early Brain-Targeted Asset With New PET Imaging Study
PremiumCompany Announcements
BMY Advances Early Brain-Targeted Asset With New PET Imaging Study
11d ago
BMY
Bristol Myers price target lowered to $66 from $67 at BofA
PremiumThe Fly
Bristol Myers price target lowered to $66 from $67 at BofA
11d ago
BMY
AI Daily: Amazon’s AWS commits $1B toward new unit
PremiumThe Fly
AI Daily: Amazon’s AWS commits $1B toward new unit
20d ago
AZN
BMY
Anthropic takes aim at pharma industry with Claude Science, STAT reports
PremiumThe Fly
Anthropic takes aim at pharma industry with Claude Science, STAT reports
20d ago
AZN
BMY
The Week That Was, The Week Ahead: Macro and Markets, June 28
PremiumMarket NewsThe Week That Was, The Week Ahead: Macro and Markets, June 28
23d ago
A
O
Bristol-Myers Squibb Advances Japanese Real-World Study of Mavacamten in Hypertrophic Cardiomyopathy
Premium
Company Announcements
Bristol-Myers Squibb Advances Japanese Real-World Study of Mavacamten in Hypertrophic Cardiomyopathy
25d ago
BMY
3 Best ETFs AI Analyst Recommends — June 22, 2026
Premium
Market News
3 Best ETFs AI Analyst Recommends — June 22, 2026
29d ago
VZ
BMY
Real-World Data on Nivolumab Plus Chemo in Japanese Gastric Cancer: What Investors Should Watch
PremiumCompany Announcements
Real-World Data on Nivolumab Plus Chemo in Japanese Gastric Cancer: What Investors Should Watch
1M ago
BMY
Bristol-Myers Squibb’s Real World Kidney Cancer Study Signals Durable Immunotherapy Momentum
PremiumCompany Announcements
Bristol-Myers Squibb’s Real World Kidney Cancer Study Signals Durable Immunotherapy Momentum
1M ago
BMY
J&J, Bristol-Myers face negotiation risk under new CMS rule, says RBC Capital
PremiumThe Fly
J&J, Bristol-Myers face negotiation risk under new CMS rule, says RBC Capital
1M ago
BMY
JNJ
CMS proposes to lock in lower prices in Medicare drug price negotiation program
PremiumThe Fly
CMS proposes to lock in lower prices in Medicare drug price negotiation program
1M ago
AZN
BMY
Bristol-Myers Squibb Advances Phase 1 Liver Study for New Drug BMS-986435
PremiumCompany AnnouncementsBristol-Myers Squibb Advances Phase 1 Liver Study for New Drug BMS-986435
1M ago
BMY
Bristol-Myers Squibb’s Mavacamten Study Signals Real‑World Momentum in Heart Drug Market
Premium
Company Announcements
Bristol-Myers Squibb’s Mavacamten Study Signals Real‑World Momentum in Heart Drug Market
1M ago
BMY
Heart-Disease Biotech Kardigan Set For $1.4B U.S. IPO
Premium
Market News
Heart-Disease Biotech Kardigan Set For $1.4B U.S. IPO
1M ago
BMY
JEF

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >